Yilmaz, Y. Et Al. 2011. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. Journal of Crohn's and Colitis , vol.5, no.5 , 402-406.

Yilmaz, Y., Yonal, O., Eren, F., Atug, O., & Hamzaoglu, H. O., (2011). Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. Journal of Crohn's and Colitis , vol.5, no.5, 402-406.

Yilmaz, YUSUF Et Al. "Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity," Journal of Crohn's and Colitis , vol.5, no.5, 402-406, 2011

Yilmaz, YUSUF Et Al. "Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity." Journal of Crohn's and Colitis , vol.5, no.5, pp.402-406, 2011

Yilmaz, Y. Et Al. (2011) . "Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity." Journal of Crohn's and Colitis , vol.5, no.5, pp.402-406.

@article{article, author={YUSUF YILMAZ Et Al. }, title={Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity}, journal={Journal of Crohn's and Colitis}, year=2011, pages={402-406} }